Best of the Breast

Best of the Breast

From the largely accepted to the relatively esoteric, breast imaging advances have taken many forms in recent years. Get a better understanding of these emerging modalities.

By Keith D. Paulsen, PhD

References

1. Pisano, E.D., Gatsonis, C., Hendrick, E., Yaffe, M., et al. (2005). Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med, 353(17), 1773-83.
2. Pisano, E.D., Hendrick, R.E., Yaffe, M.J., Baum, J.K., et al. (2008). Diagnostic accuracy of digital versus film mammography: Exploratory analysis of selected population subgroups in DMIST. Radiology, 246(2), 376-83.
3. Tosteson, A.N., Stout, N.K., Fryback, D.G., Acharyya, S., et al. (2008). Cost-Effectiveness of digital mammography breast cancer screening. Annals Int Med, 148, 1-10.
4. Park, J.M., Franken, E.A., Garg, M., Fajardo, L.L., et al. (2007). Breast tomosynthesis: Present considerations and future applications. RadioGraphics, 27(Suppl 1), S231-40.
5. Poplack, S.P., Tosteson, T.D., Kogel, C.A., & Nagy, H.M. (2007). Digital breast tomosynthesis: Initial experience in 98 women with abnormal digital screening mammography. Am J Roentgenol, 189(3), 616-23.
6. Good, W.F., Abrams, G.S., Catullo, V.J., & Chough, D.M. (2008). Digital breast tomosynthesis: A pilot observer study. Am J Roentgenol, 190(4), 865-9.
7. Boone, J.M., Nelson, T.R., Lindfors, K.K., & Seibert, J.A. (2001). Dedicated breast CT: radiation dose and image quality evaluation. Radiology, 221(3), 657-67.
8. Shaw, C.C., Chen, L., Altuntas, M., Tu, S., et al. (2005). Cone beam breast CT with a flat panel detector: simulation, implementation and demonstration. Proc IEEE Eng Med Biol Soc, 4, 4461-4.
9. Yang, W.T., Carkaci, S., Chen, L., & Lai, C.J. (2007). Dedicated cone-beam breast CT: Feasibility study with surgical mastectomy specimens. Am J Roentgenol, 2007, 189(6), 1312-5.
10. Lindfors, K.K., Boone, J.M., Nelson, T.R., Yang, K., et al. (2008). Dedicated breast CT: Initial clinical experience. Radiology, 246(3), 725-33.
11. Bluemke, D.A., Gatsonis, C.A., Chen, M.H., DeAngelis, G.A., et al. (2004). Magnetic resonance imaging of the breast prior to biopsy. JAMA, 292(22), 2735-42.
12. Warner, E., Plewes, D.B., Shumak, R.S., Catzavelos, G.C., et al. (2001). Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol, 19(15), 3524-31.
13. Stoutjesdijk, M.J., Boetes, C., Jager, G.J., Beex, L., et al. (2001). Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst, 93(14), 1095-102.
14. Saslow, D., Boetes, C., Burke, W., Harms, S., et al. (2007). American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography, CA: a cancer journal for clinicians, 57(2), 75-89.
15. FDA U.S., Public Health Advisory: Update on magnetic resonance imaging (MRI) contrast agents containing gadolinium and nephrogenic fibrosing dermopathy. Created Dec. 22, 2006; updated May 23, 2007. www.fda.gov/Cder/Drug/advisory/gadolinium_agents_20061222.htm [Accessed April 29, 2008].
16. Ophir, J., Alam, S.K., Garra, B.S., Kallel, F., et al. (2002). Elastography: Imaging the elastic properties of soft tissues with ultrasound. Journal of Med Ultrasound, 29(4), Winter, 155-71.
17. Duric, N., Li, C., Littrup, P., Glide-Hurst, C., et al. (2008). Multi-modal breast imaging with ultrasound tomography. Medical Imaging 2008: Ultrasonic Imaging and Signal Processing. Edited by McAleavey, S.A., & D'hooge, J. Proceedings of the SPIE, 6920, 69200O-8.
18. Kruger, R.A., et al. (2000). Breast cancer in vivo: Contrast enhancement with thermoacoustic CT at 434 MHz-feasibility study. Radiology, 216(1), 279-83.
19. Hisadi, K., Tonami, N., Miyamae, T., et al. (1978). Clinical evaluation of tumor imaging with 201 Tl chloride. Radiology, 129, 497-500.
20. Minn, H. & Soini, I. (1989). [18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer. Eur J Nucl Med, 15, 61-6.
21. Taillefer, R. (1999). The role of 99mTc sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med, 29, 16-40.
22. Waxman, A,D. (1997). The role of (99m) Tc methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med, 27(1), 40-54.
23. Tofani, A., Sciuto, R., Semprebene, A., et al. (1999). 99Tcm- MIBI scintimammography in 300 consecutive patients: Factors that may affect accuracy. Nucl Med Commun, 20, 1113-21.
24. Mekhmandarov, S., Sandbank, J., Cohen, M., Lelcuk, S., et al. (1998). Technetium- 99m-MIBI scintimammography in palpable and nonpalpable breast lesions. J Nucl Med, 39, 86-91.
25. Rhodes, D.J., O'Connor, M.K., Phillips, S.W., Smith, R.L., et al. (2005). Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clin Proc, 80(1), 24-30
26. O'Connor, M.K., Phillips, S.W., Hruska, C.B., et al. (2007). Molecular breast imaging: Advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast J, 13(1), 3-11.
27. Wahl, R.L., Cody, R.L., Hutchins, G.D., & Mudgett, E.E. (1991). Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology, 179, 765-70.
28. Hoh, C.K., Hawkins, R.A., Glaspy, J.A., et al. (1993). Cancer detection with whole-body PET using 2-[18F]fluoro- 2-deoxy-D-glucose. J Comput Assist Tomogr, 17, 582-89.
29. Scheidhauer, K., Schari, A., Pietrzyk, U., et al. (1996). Quantitative [18F]FDG positron emission tomography in primary breast cancer: Clinical relevance and practicability. Eur J Nucl Med, 23,618-23.
30. Eubank, W.B. & Mankoff, D.A. (2005). Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med, 35, 84-99.
31. Schilling, K., Conti, P., Adler, L., & Tafra, L. (2008). The role of positron emission mammography in breast cancer imaging and management, Applied Radiology, 37(4), 26-36.
32. Tafra L, Cheng Z, Uddo J, et al. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer. Am J Surg. 2005;190:628-632.
33. Berg WA, Weinberg IN, Narayanan D, et al. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J. 2006;12(4): 309-323.
34. Poplack, S.P., Tosteson, T.D., Wells, W.A., Pogue, B.W., et al (2007). Electromagnetic breast imaging: Pilot result in women with abnormal mammography. Radiology, 243(2), 350-9.
35. Brooksby, B.A., Pogue, B.W., Jiang, S., Dehghani, H., et al. (2006). Imaging breast adipose and fibroglandular tissue molecular signatures using hybrid MRI-guided near-infrared spectral tomography. PNAS, 103(23), 8828-33.
36. Carpenter, C.M., Pogue, B.W., Jiang, S., Dehghani, H., et al. (2007). Image-guided optical spectroscopy provides molecular-specific information in vivo: MRI-guided spectroscopy of breast cancer hemoglobin, water, and scatterer size. Optics Letters, 32(8), 933-5.